Advancing computational biology and bioinformatics research through open innovation competitions.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 08 04 2019
accepted: 22 08 2019
entrez: 28 9 2019
pubmed: 29 9 2019
medline: 17 3 2020
Statut: epublish

Résumé

Open data science and algorithm development competitions offer a unique avenue for rapid discovery of better computational strategies. We highlight three examples in computational biology and bioinformatics research in which the use of competitions has yielded significant performance gains over established algorithms. These include algorithms for antibody clustering, imputing gene expression data, and querying the Connectivity Map (CMap). Performance gains are evaluated quantitatively using realistic, albeit sanitized, data sets. The solutions produced through these competitions are then examined with respect to their utility and the prospects for implementation in the field. We present the decision process and competition design considerations that lead to these successful outcomes as a model for researchers who want to use competitions and non-domain crowds as collaborators to further their research.

Identifiants

pubmed: 31560691
doi: 10.1371/journal.pone.0222165
pii: PONE-D-19-10061
pmc: PMC6764653
doi:

Substances chimiques

Antibodies 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0222165

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG008699
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Drug Discov Today. 2012 Dec;17(23-24):1289-98
pubmed: 22889966
Methods Mol Biol. 2017;1526:257-270
pubmed: 27896747
Front Immunol. 2013 Sep 11;4:265
pubmed: 24062737
Cell. 2017 Nov 30;171(6):1437-1452.e17
pubmed: 29195078
Nat Methods. 2018 Aug;15(8):587-590
pubmed: 30065368
Nat Methods. 2016 Apr;13(4):310-8
pubmed: 26901648
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
JAMA Oncol. 2019 May 1;5(5):654-661
pubmed: 30998808
Nat Biotechnol. 2013 Feb;31(2):108-11
pubmed: 23392504
PLoS Comput Biol. 2018 Mar 15;14(3):e1005992
pubmed: 29543809
Nat Immunol. 2015 Jun;16(6):571-6
pubmed: 25988889
Nature. 2010 Aug 5;466(7307):756-60
pubmed: 20686574
Nat Rev Genet. 2016 Jul 15;17(8):470-86
pubmed: 27418159
Nat Biotechnol. 2014 Dec;32(12):1202-12
pubmed: 24880487
Science. 2006 Sep 29;313(5795):1929-35
pubmed: 17008526

Auteurs

Andrea Blasco (A)

Laboratory for Innovation Science at Harvard, Harvard University, Cambridge, MA, United States of America.
Institute for Quantitative Social Science, Harvard University, Cambridge, MA, United States of America.
The Broad Institute, Cambridge, MA, United States of America.

Michael G Endres (MG)

Laboratory for Innovation Science at Harvard, Harvard University, Cambridge, MA, United States of America.
Institute for Quantitative Social Science, Harvard University, Cambridge, MA, United States of America.

Rinat A Sergeev (RA)

Laboratory for Innovation Science at Harvard, Harvard University, Cambridge, MA, United States of America.
Harvard Business School, Harvard University, Boston, MA, United States of America.

Anup Jonchhe (A)

The Broad Institute, Cambridge, MA, United States of America.

N J Maximilian Macaluso (NJM)

The Broad Institute, Cambridge, MA, United States of America.

Rajiv Narayan (R)

The Broad Institute, Cambridge, MA, United States of America.

Ted Natoli (T)

The Broad Institute, Cambridge, MA, United States of America.

Jin H Paik (JH)

Laboratory for Innovation Science at Harvard, Harvard University, Cambridge, MA, United States of America.
Harvard Business School, Harvard University, Boston, MA, United States of America.

Bryan Briney (B)

Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States of America.

Chunlei Wu (C)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States of America.

Andrew I Su (AI)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States of America.

Aravind Subramanian (A)

The Broad Institute, Cambridge, MA, United States of America.

Karim R Lakhani (KR)

Laboratory for Innovation Science at Harvard, Harvard University, Cambridge, MA, United States of America.
Harvard Business School, Harvard University, Boston, MA, United States of America.
National Bureau of Economic Research, Cambridge, MA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH